Početna › Vazookluzivne krize › Georgia
Kliničke studije za Vazookluzivne krize u državi Georgia
4 studija za Vazookluzivne krize traži sudionike na lokacijama u državi Georgia.
Gradovi u državi Georgia
Službeni tekst studije (engleski)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Augusta University Georgia, Augusta
- WCG Sonar Clinical Research, Riverdale
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06439082Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT07224360Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
- Augusta University Georgia, Augusta
U tijeku regrutacijaFaza 4
6 Months – 100 Years · Oba spola · Ažurirano 8. lip 2026. · NCT04657822Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.